Resource Library
» Compendium of Infection Control and Prevention Resources » • Hepatitis C Monitoring and Referral
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney DiseaseSource: Kidney International Supplements Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group
KDIGO Guidelines "Hepatitis C in CKD" (2018)The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease represents a complete update of the prior guideline published in 2008.
CDC Urging Dialysis Providers and Facilities to Assess and Improve Infection Control Practices to Stop Hepatitis C Virus Transmission in Patients Undergoing HemodialysisSource: Centers for Disease Control and Prevention (CDC) Distributed via the CDC Health Alert Network Wednesday, January 27, 2016, 10:30 EST (10:30 AM EST) CDCHAN-00386
AJKDBlog: Caring for Patients with Hepatitis C and CKD in the Modern Era: The 2018 KDIGO GuidelinePosted on February 22, 2019 by AJKDblog in Commentary
CDC/NTDS Hepatitis C Testing and Monitoring AlgorithmDespite dialysis facility policies to minimize the risk of infection, transmission of hepatitis C virus (HCV) remains a real risk for patients with chronic kidney disease (CKD). HCV-infected patients may develop chronic liver disease, and also may be at increased risk of developing diabetes mellitus and renal graft injury should an infected patient receive renal transplant. Strict attention to infection control practices and surveillance to detect hepatitis C can limit its spread within dialysis units. Antiviral regimens can cure HCV infection, leading to eradication of this virus among already infected hemodialysis patients. This algorithm is intended to help healthcare professionals involved in the care of hemodilaysis patients identify infected patients and refer them for antiviral therapy.
